author_facet Sakuma
Sakuma
author Sakuma
spellingShingle Sakuma
Oncology Reports
ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
Cancer Research
Oncology
General Medicine
author_sort sakuma
spelling Sakuma 1021-335X Spandidos Publications Cancer Research Oncology General Medicine http://dx.doi.org/10.3892/or.2010.1123 ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis Oncology Reports
doi_str_mv 10.3892/or.2010.1123
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9vci4yMDEwLjExMjM
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9vci4yMDEwLjExMjM
institution DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
imprint Spandidos Publications, 2011
imprint_str_mv Spandidos Publications, 2011
issn 1021-335X
issn_str_mv 1021-335X
language English
mega_collection Spandidos Publications (CrossRef)
match_str 2011abt263abcl2inhibitorenhancesthesusceptibilityoflungadenocarcinomacellstreatedwithsrcinhibitorstoanoikis
publishDateSort 2011
publisher Spandidos Publications
recordtype ai
record_format ai
series Oncology Reports
source_id 49
title ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_unstemmed ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_full ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_fullStr ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_full_unstemmed ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_short ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_sort abt-263, a bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with src inhibitors to anoikis
topic Cancer Research
Oncology
General Medicine
url http://dx.doi.org/10.3892/or.2010.1123
publishDate 2011
physical
description
container_issue 3
container_start_page 0
container_title Oncology Reports
container_volume 25
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792334958994391051
geogr_code not assigned
last_indexed 2024-03-01T14:36:56.448Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=ABT-263%2C+a+Bcl-2+inhibitor%2C+enhances+the+susceptibility+of+lung+adenocarcinoma+cells+treated+with+Src+inhibitors+to+anoikis&rft.date=2011-03-01&genre=article&issn=1021-335X&volume=25&issue=3&jtitle=Oncology+Reports&atitle=ABT-263%2C+a+Bcl-2+inhibitor%2C+enhances+the+susceptibility+of+lung+adenocarcinoma+cells+treated+with+Src+inhibitors+to+anoikis&aulast=Sakuma&rft_id=info%3Adoi%2F10.3892%2For.2010.1123&rft.language%5B0%5D=eng
SOLR
_version_ 1792334958994391051
author Sakuma
author_facet Sakuma, Sakuma
author_sort sakuma
container_issue 3
container_start_page 0
container_title Oncology Reports
container_volume 25
description
doi_str_mv 10.3892/or.2010.1123
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzg5Mi9vci4yMDEwLjExMjM
imprint Spandidos Publications, 2011
imprint_str_mv Spandidos Publications, 2011
institution DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15
issn 1021-335X
issn_str_mv 1021-335X
language English
last_indexed 2024-03-01T14:36:56.448Z
match_str 2011abt263abcl2inhibitorenhancesthesusceptibilityoflungadenocarcinomacellstreatedwithsrcinhibitorstoanoikis
mega_collection Spandidos Publications (CrossRef)
physical
publishDate 2011
publishDateSort 2011
publisher Spandidos Publications
record_format ai
recordtype ai
series Oncology Reports
source_id 49
spelling Sakuma 1021-335X Spandidos Publications Cancer Research Oncology General Medicine http://dx.doi.org/10.3892/or.2010.1123 ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis Oncology Reports
spellingShingle Sakuma, Oncology Reports, ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis, Cancer Research, Oncology, General Medicine
title ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_full ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_fullStr ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_full_unstemmed ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_short ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
title_sort abt-263, a bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with src inhibitors to anoikis
title_unstemmed ABT-263, a Bcl-2 inhibitor, enhances the susceptibility of lung adenocarcinoma cells treated with Src inhibitors to anoikis
topic Cancer Research, Oncology, General Medicine
url http://dx.doi.org/10.3892/or.2010.1123